Log In
BCIQ
Print this Print this
 

RBX2477

  Manage Alerts
Collapse Summary General Information
Company Rebiotix Inc.
DescriptionLive, broad-spectrum microbiota suspension
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationLiver disease
Indication DetailsTreat hepatic encephalopathy (HE)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today